INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Deferred Revenue of $22.90 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-09
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $22.90M, a 937.50% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $1.05M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$410.50K, a 228.82% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$16.53M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$13.69M, a 996.08% decline from fiscal 2016.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $1.53M, a 85.01% decline from fiscal 2015.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2015 was $10.19M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2014 was -$260.72K, a 108.20% decline from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-03-31 | $22.90M 10-Q · filed 2018-05-09 | $23.95M derived: sum of 2 quarters · filed 2018-05-09 | $23.54M derived: sum of 3 quarters · filed 2018-05-09 | $7.00M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $636.58K derived: sum of 2 quarters · filed 2018-03-14 | -$15.90M derived: sum of 3 quarters · filed 2018-03-14 | -$13.69M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$410.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$16.94M derived: sum of 2 quarters · filed 2017-11-08 | -$14.74M 10-Q · filed 2017-11-08 | -$14.85M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | -$16.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$14.33M 10-Q · filed 2017-08-08 | -$14.44M derived: sum of 3 quarters · filed 2018-05-09 | -$14.12M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | $2.21M 10-Q · filed 2018-05-09 | $2.09M derived: sum of 2 quarters · filed 2018-05-09 | $2.41M derived: sum of 3 quarters · filed 2018-05-09 | $2.31M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | -$114.79K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $203.86K derived: sum of 2 quarters · filed 2018-03-14 | $107.41K derived: sum of 3 quarters · filed 2018-03-14 | $1.53M 10-K · filed 2018-03-14 |
| 2016-09-30 | $318.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $222.20K derived: sum of 2 quarters · filed 2017-11-08 | $1.64M 10-Q · filed 2017-11-08 | $2.21M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$96.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.32M 10-Q · filed 2017-08-08 | $1.89M derived: sum of 3 quarters · filed 2018-03-14 | $14.41M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $1.42M 10-Q · filed 2017-05-10 | $1.99M derived: sum of 2 quarters · filed 2018-03-14 | $14.51M derived: sum of 3 quarters · filed 2018-03-14 | $14.45M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $565.93K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $13.09M derived: sum of 2 quarters · filed 2018-03-14 | $13.03M derived: sum of 3 quarters · filed 2018-03-14 | $10.19M 10-K · filed 2018-03-14 |
| 2015-09-30 | $12.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $12.46M derived: sum of 2 quarters · filed 2016-11-09 | $9.63M 10-Q · filed 2016-11-09 | $9.83M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | -$57.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$2.90M 10-Q · filed 2016-08-08 | -$2.69M derived: sum of 3 quarters · filed 2017-03-15 | -$2.63M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | -$2.84M 10-Q · filed 2016-05-09 | -$2.63M derived: sum of 2 quarters · filed 2017-03-15 | -$2.57M derived: sum of 3 quarters · filed 2017-03-15 | -$3.25M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $207.69K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $267.05K derived: sum of 2 quarters · filed 2017-03-15 | -$408.22K derived: sum of 3 quarters · filed 2017-03-15 | -$260.72K 10-K · filed 2017-03-15 |
| 2014-09-30 | $59.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$615.91K derived: sum of 2 quarters · filed 2015-11-09 | -$468.40K 10-Q · filed 2015-11-09 | $1.36M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | -$675.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$527.76K 10-Q · filed 2015-08-10 | $1.30M derived: sum of 3 quarters · filed 2016-03-14 | $2.92M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $147.50K 10-Q · filed 2015-05-11 | $1.98M derived: sum of 2 quarters · filed 2016-03-14 | $3.59M derived: sum of 3 quarters · filed 2016-03-14 | $3.48M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $3.45M derived: sum of 2 quarters · filed 2016-03-14 | $3.33M derived: sum of 3 quarters · filed 2016-03-14 | $3.18M 10-K · filed 2016-03-14 |
| 2013-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.50M derived: sum of 2 quarters · filed 2014-11-10 | $1.35M 10-Q · filed 2014-11-10 | $1.62M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$113.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$266.89K 10-Q · filed 2014-08-11 | $697.00 derived: sum of 3 quarters · filed 2015-03-16 | $55.61K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | -$153.09K 10-Q · filed 2014-05-12 | $114.50K derived: sum of 2 quarters · filed 2015-03-16 | $169.41K derived: sum of 3 quarters · filed 2015-03-16 | $161.13K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $267.58K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $322.49K derived: sum of 2 quarters · filed 2015-03-16 | $314.21K derived: sum of 3 quarters · filed 2015-03-16 | $282.05K 10-K · filed 2015-03-16 |
| 2012-09-30 | $54.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $46.63K derived: sum of 2 quarters · filed 2013-11-12 | $14.46K 10-Q · filed 2013-11-12 | $20.35K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$8.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$40.45K 10-Q · filed 2013-08-09 | -$34.56K derived: sum of 3 quarters · filed 2014-03-17 | -$180.30K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | -$32.17K 10-Q · filed 2013-05-10 | -$26.28K derived: sum of 2 quarters · filed 2014-03-17 | -$172.02K derived: sum of 3 quarters · filed 2014-03-17 | -$205.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $5.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$139.85K derived: sum of 2 quarters · filed 2014-03-17 | -$172.83K derived: sum of 3 quarters · filed 2014-03-17 | -$333.73K 10-K · filed 2014-03-17 |
| 2011-09-30 | -$145.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$178.72K derived: sum of 2 quarters · filed 2012-11-07 | -$339.61K 10-Q · filed 2012-11-07 | -$410.96K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$32.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$193.87K 10-Q · filed 2012-08-09 | -$265.22K derived: sum of 3 quarters · filed 2013-03-18 | $135.25K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$160.89K 10-Q · filed 2012-05-09 | -$232.24K derived: sum of 2 quarters · filed 2013-03-18 | $168.23K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | -$71.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $329.12K derived: sum of 2 quarters · filed 2013-03-18 | $140.76K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $400.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $212.10K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$188.36K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$4.67M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |